Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

180 Life Sciences Corp (ATNF)

3.45   0.36 (11.65%) 01-20 23:14
Open: 3.05 Pre. Close: 3.09
High: 3.64 Low: 3.02
Volume: 3,044,037 Market Cap: 73M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.644 - 3.658 3.658 - 3.669
Low: 2.989 - 3.003 3.003 - 3.015
Close: 3.426 - 3.451 3.451 - 3.471

Technical analysis

as of: 2021-01-20 4:44:35 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.25     One year: 4.97
Support: Support1: 2.80    Support2: 2.28
Resistance: Resistance1: 3.64    Resistance2: 4.25
Pivot: 2.83
Moving Average: MA(5): 3.17     MA(20): 2.82
MA(100):     MA(250):
MACD: MACD(12,26): -0.04     Signal(9): -0.20
Stochastic oscillator: %K(14,3): 72.20     %D(3): 69.34
RSI: RSI(14): 61.51
52-week: High: 11.50  Low: 1.90  Change(%): -67.9
Average Vol(K): 3-Month: 102226  10-Days: 155977

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ATNF has closed above the upper band by 7.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 11 Jan 2021
BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) to Present at the Biotech Showcase(TM) Digital 2021 Conference -

Tue, 05 Jan 2021
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference - GlobeNewswire

Thu, 03 Dec 2020
One biotech's odd journey to go public clears path to treat crippling conditions - San Francisco Business Times

Fri, 27 Nov 2020
SPAC biotech 180 Life Sciences to ring Nasdaq opening bell today - Seeking Alpha

Mon, 23 Nov 2020
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants - GlobeNewswire

Tue, 17 Nov 2020
BioMedNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Stockholders -

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 21
Shares Float (M) 3
% Held by Insiders 57.18
% Held by Institutions 4.81
Shares Short (K) 24
Shares Short P. Month (K) 8

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -42.2
Return on Equity (ttm) -125.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.991
Qtrly Earnings Growth
Operating Cash Flow (M) -3
Levered Free Cash Flow (M) -3

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -22.75

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.